Lipicure 20 Tablet contains Atorvastatin 20 mg, a lipid-lowering agent belonging to the statin class. It is primarily indicated for the management of hypercholesterolemia and mixed dyslipidemia, helping to reduce elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Atorvastatin exerts its effect by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production in the liver and upregulation of LDL receptors, thereby enhancing clearance of LDL from the bloodstream. Lipicure 20 is used as an adjunct to diet and lifestyle modifications, including exercise and weight control, to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and angina in patients with established coronary heart disease or those at high risk. The medication is generally well-tolerated; however, potential adverse effects include myopathy, elevated liver enzymes, and gastrointestinal disturbances. Regular monitoring of liver function tests and creatine kinase levels is recommended during therapy. Lipicure 20 should be used with caution in patients with hepatic impairment or a history of muscle disorders and is contraindicated during pregnancy and lactation.